Enhanced Blood Cleansing with Neprinol*
Enzymes are proteins that act as catalysts for the millions of chemical reactions that are essential for the survival and health of the body. Nearly every process that takes place throughout our lives depends on the proper functioning of a number of different enzymes, from breaking down food during digestion to building, maintaining and repairing every single cell and tissue throughout the body.
There are two main types of enzymes. Digestive Enzymes are the enzymes responsible for breaking down food in our digestive tract so that its nutritional components can be absorbed and used for nourishment. These enzymes, which include lipase, amylase and protease, are naturally produced by the pancreas. Unfortunately, production tends to decrease with increasing age. Systemic Enzymes, like their digestive counterparts, also serve to break down larger (macro) particles into much smaller (micro) nutrients. However, instead of being confined to the digestive tract, systemic enzymes are designed to survive degradation by stomach acid and other digestive processes so that they can be taken up through the intestines and lymphatic system and spread throughout the body via the lymph and circulatory systems .
Neprinol, by Arthur Andrew Medical, is a revolutionary blend of systemic enzymes and antioxidants specially formulated to support wellness by cleaning up the blood.* The roughly 5 liters of blood that flow throughout the adult human body is essentially the river of life. Its currents help transport and distribute vital oxygen and nutrients to every cell, as well as dispose of carbon dioxide and other cellular wastes. Just like with any river, if the wastes and toxins from the cells are not adequately cleared out of the bloodstream, often due to a lack of enzymes or sluggish liver function, the trash starts to build up, creating a sort of "dam" of the detoxification pathways vital for good health .
Supplementation with systemic enzymes like those found in Neprinol supports healthy levels of cellular debris, circulating immune complexes, decayed or oxidized cells, fibrin and fatty proteins in the blood [2-24].* Enzymes use a lock and key mechanism to adhere to and break down dead, decaying or non-living particles, leaving living tissue undisturbed.* If the enzymatic key doesn't fit, which is the case with living tissue, then the enzyme leaves it alone. Therefore, unlike antibiotics, vaccines, medications and other pharmaceutical chemicals that serve a purpose in supporting symptom reduction but are also potentially destructive to living tissues, enzymes naturally only target wastes and excess junk within the body, without harming vital organs and tissues in the process.*
Neprinol Supports the Breakdown of Unhealthy Macroparticles*
Recent medical breakthroughs have led researchers to use the systemic enzymes found in Neprinol's unique formulation to aid in supporting the breakdown and clearing of a number of different macroparticles from the bloodstream [2-24].*
Undigested Food Particles
A number of causative factors of degenerative health often originate in the digestive system and can eventually radiate outward into the circulatory system and the rest of the body. As we age, we produce far less of the digestive enzymes needed to maintain optimal health. The gradual breakdown of the intestinal lining coupled with hindered digestion can allow contaminates such as undigested food particles to enter the bloodstream. These contaminates can accumulate over time, causing the blood to become thick and abrasive, eventually leading to cardiovascular and autoimmune complications [25-27].*
Since lipase is able to break down fats into their constituent fatty acids, and protease and other proteolytic enzymes degrade proteins into amino acids, these systemic enzymes found in Neprinol help support normal levels of undigested food particles in the blood [2,3].* As these smaller micronutrients are much easily absorbed into the cells, they have the potential to be utilized as substrates in energy metabolism or stored by the body.*
Clotting Factors and Fibrin
A number of the systemic enzymes found in Neprinol function as circulatory purifiers, assisting in the digestion of debris from the cardiovascular system, which softens blood plasma and reduces stress on the arterial walls .* In addition, by digesting cellular debris, such as fibrin and other proteins, systemic enzymes assist in supporting normal healthy blood flow and viscosity [4-6].*
Nattokinase, a fibrinolytic enzyme, has been shown to aid in the breakdown of clotting factors such as fibrinogen, factor VII and factor VIII in healthy humans , while bromelain, a pineapple extract, has been identified in animal and human studies to have properties that support normal blood viscosity, such as preventing the aggregation of platelets [8,9].* According to doctors who recommend Neprinol, their patients retain clean healthy blood similar to people who are much younger.*
Lipids are fat-like substances found in circulation that are needed to create hormones and deliver nutrients to the body. However, when these lipids become oxidized in the blood they can build up on the walls of arteries, narrowing the opening of the vessel. When this happens, the flow of the blood slows down, limiting its ability to bring nutrients and oxygen to the cells and to take away waste products. Clinical studies have shown that nattokinase, amla and lipase assist in promoting a healthy lipid profile within the bloodstream [10-18].*
Circulating Immune Complexes (CICs)
The immune system is the body's primary defense against foreign invaders like bacteria and foreign proteins. One of the ways the immune system protects the body is by producing proteins called antibodies. Antibodies are formed in response to another type of protein called an antigen (anything foreign or different from a normal body protein). The antibody then attaches to the antigen in an attempt to deactivate it, creating an immune complex in the bloodstream.
If the CICs are small enough, a type of white blood cell known as macrophages are usually able to eat them up like Pac Men and transport them to the liver or the spleen . However, over time the macrophages can become so saturated with CICs that they can no longer remove them from the bloodstream. When this happens, the CICs deposit their contents in places like the kidneys, joints and blood vessel walls, where they can trigger inflammation and tissue damage that can eventually lead to illness [3,29-33].
The proteolytic enzymes found in Neprinol help degrade and eliminate CICs, supporting healthy levels of inflammation as well as the body's natural repair processes [3,19].*
Is Neprinol Safe?
No serious or adverse side effects have been reported from taking systemic enzymes such as those in Neprinol.* Clinical studies have shown that even extremely large doses of these enzymes are not toxic. If you are taking blood-thinning medication or are pregnant or nursing, you should consult with your physician before taking Neprinol.
* These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure or prevent any disease. For all conditions or illnesses, see a healthcare professional for a full evaluation, diagnosis or treatment plan.
- Cichoke AJ. The Complete Book of Enzyme Therapy. New York, NY: Avery; 1999.
- Rachman B. Unique Features and Application of Non-Animal Derived Enzymes. Clin Nutr Insights. 1997;5(10).
- Cutler E. Why Enzymes Are Essential to a Healthy Immune System. Townsend Lettr. 275.
- Pais E, Alexy T, Holsworth RE Jr, Meise HJ. Effects of nattokinase, a pro-fibrinolytic enzyme, on red blood cell aggregation and whole blood viscosity. Clin Hemorheol Microcirc. 2006;35:139-42.
- Ito H, Suzuki T. Effect of oral administration of nattokinase extract on blood mobility. Society Analyti Bio-Sci. 2002;25(4).
- Ernst E, Matrai A. Oral Therapy with proteolytic enzymes for modifying blood rheology. Klin Wschr. 1987;65:994.
- Hsia CH, Shen MC, Lin JS, et al. Nattokinase decreases plasma levels of fibrinogen, factor VII, and factor VIII in human subjects. Nutr Res. 2009;29(3):190-6.
- Juhasz B, Thirunavukkarasu M, Pant R, et al. Bromelain induces cardioprotection against ischemia-reperfusion injury through Akt/FOXO pathway in rat myocardium. Am J Physiol Heart Circ Physiol. 2008;294(3):H1365-70.
- Heinicke RM, van der Wal L, Yokoyama M. Effect of bromelain on human platelet aggregation. Experientia. 1972;28:844-5.
- Olivecrona G, Olivecrona T. Triglyceride lipases and atherosclerosis. Curr Opin Lipidol. 2010;21(5):409-15.
- McPherson JC, Moore WT, Pope JL, Tidwell HC. Effect of Lipase Ingestion on Blood Lipid Levels. Proc Soc Exp Biol Med. 1964;115:514-7.
- Wu D-J, Lin C-S, Lee M-Y. Lipid-Lowering Effect of Nattokinase in Patients with Primary Hypercholesterolemia. Acta Cardiol Sin. 2009;25:26-30.
- Iwai K, Nakaya N, Kawasaki Y, et al. Antioxidant functions of natto, a kind of fermented soybean: effect on LDL oxidation and lipid metabolism in cholesterol-fed rats. J Agric Food Chem. 2002;50:3597-3601.
- Yokota T, Hattori T, Ohishi H, et al. The effect of antioxidant-containing fraction from fermented soybean on atherosclerosis development in cholesterol-fed rabbits. Lebensm-Wiss Technol. 1996;29:751-5.
- Akhtar MS, Ramzan A, Ali A, Ahmad M. Effect of Amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients. Int J Food Sci Nutr. 2011;62(6):609-16.
- Antony B, Merina B, Sheeba V. Amlamax in the management of dyslipidemia in humans. Indian J Pharm Sci. 2008;70(4):504-7.
- Jacob A, Pandey M, Kapoor S, Saroja R. Effect of the Indian gooseberry (amla) on serum cholesterol levels in men aged 35-55 years. Eur J Clin Nutr. 1988;42(11):939-44.
- Anila L, Vijayalakshmi NR. Flavonoids from Emblica officinalis and Mangifera indica-effectiveness for dyslipidemia. J Ethnopharmacol. 2002;79(1):81-7.
- Kunze R, Ransberger K, et al. Humoral immunomodulatory capacity of proteases in immune complex decomposition and formation. First International symposium on combination therapies, Washington, DC; 1991.
- Jager H. Hydrolytic Enzymes in the therapy of HIV disease. Zeitschr Allgemeinmed. 1990;19:160.
- Bartsch W. The treatment of herpes zoster using proteolytic enzymes. Der Informierte Arzt. 1974;2:424-9.
- Scheef W. Enzymtherapie, Lehrbruch der Naturheilver fahren. Hippokrates Verlag Bd. 1987;11(Suppl):95-103.
- Billigmann P. Enzyme therapy—an alternative in treatment of herpes zoster. A controlled study of 192 patients [translated from German]. Fortschr Med. 1995;113:43-8.
- Kleine MW, Stauder GM, Beese EW. The intestinal absorption of orally administered hydrolytic enzymes and their effects in the treatment of acute herpes zoster as compared with those of oral acyclovir therapy. Phytomedicine. 1995;2:7-15.
- Koenig W. Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemost. 2003;89:601-9.
- Eidelman RS, Hennekens CH. Fibrinogen: a predictor of stroke and marker of atherosclerosis. Eur Heart J. 2003;24:499-500.
- Nesheim M. Myocardial infarction and the balance between fibrin deposition and removal. Ital Heart J. 2001;2:641-5.
- Suzuki Y, Kondo K, Matsumoto Y, et al. Dietary supplementation of fermented soybean, natto, suppresses intimal thickening and modulates the lysis of mural thrombi after endothelial injury in rat femoral artery. Life Sci. 2003;73:1289-98.
- Nydegger UE, Lambert PH, Gerber H, Miescher PA. Circulating Immune Complexes in the Serum in Systemic Lupus Erythematosus and in Carriers of Hepatitis B Antigen: Quantitation by Binding to Radiolabeled Clq. J Clin Invest. 1974;54(2):297-309.
- Singh VK, Tingle AJ, Schulzer M. Rubella-associated arthritis. II. Relationship between circulating immune complex levels and joint manifestations. Ann Rheum Dis. 1986;45(2):115-9.
- Rosenbaum JT, Theofilopoulos AN, McDevitt HO, Pereira AB, Carson D, Calin A. Presence of circulating immune complexes in Reiter's syndrome and ankylosing spondylitis. Clin Immunol Immunopathol. 1981;18(2):291-7.
- Jewell DP, MacLennan ICM. Circulating immune complexes in inflammatory bowel disease. Clin Exp Immunol. 1973;14(2):219-26.
- Jewell DP, Maclennan IC, Truelove SC. Circulating immune complexes in ulcerative colitis and Crohn's disease. Gut. 1972;13(10):839-40.